Sinopharm Group Ltd H
$14.64Change from previous close: −0.61%Absolute change: −$0.09
Valuation
Data as of October 3, 2026
Valuation multiples
- Market cap
- $45.97B
- Enterprise value
- $147.38B
- P/E (trailing 12 months)
- 5.54
- Forward P/E
- 4.94
- PEG
- 2.26
- Price/book
- 0.46
- Price/sales
- 0.08
- EV/EBITDA
- 7.84
- EV/revenue
- 0.26
Profitability and growth
- Gross margin
- 7.1%
- Operating margin
- 3.0%
- Net margin
- 1.2%
- ROE
- 8.0%
- ROA
- 2.6%
- Revenue growth (year over year)
- -1.6%
- Earnings growth (year over year)
- 0.4%
Financial health
- Total cash
- $31.04B
- Total debt
- $81.32B
- Debt/equity
- 0.60
- Current ratio
- 1.40
- Quick ratio
- 1.04
Dividends
- Annual dividend per share
- $0.79
- Dividend yield
- 5.4%
- Payout ratio
- 30.2%
- Ex-dividend date
- June 23, 2026
Analysts and estimates
- Average price target
- $21.10
- Median price target
- $21.05
- High price target
- $27.75
- Low price target
- $17.04
- Analysts with a price target
- 15
- Forward EPS
- $2.98
- EPS estimate, current year
- $2.37
Shares and trading
- Beta
- 0.44
- Average volume
- 4.72M
- Shares outstanding
- 1.34B
- Float
- 1.27B
- Institutional ownership
- 74.2%
- Insider ownership
- 0.0%